SQZ Biotechnologies Co — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$21.5M

Net Income/Loss (FY2022)

-$79.5M

Total Assets (FY2022)

$99.9M

Total Equity (FY2022)

$57.1M

Cash Flows from Operating Activities (FY2022)

-$83.5M

Source: SQZ Biotechnologies Co 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.